A Stock Analysis: Buy, Sell, or Hold?
A - Agilent Technologies Inc.
$134.04
-0.25 (-0.19%)
▼
5d:
+2.63%
30d:
+1.84%
90d:
+16.5%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 26, 2026
Smart Money Accumulation
None View Scanner →
Strength: 6.2/10
Get Alerted When A Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: A shows positive signals but monitor for confirmation. Market pricing in 1.1% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: A shows positive signals but monitor for confirmation. Market pricing in 1.1% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$177.85
Based on 6.6% avg growth
INTRINSIC VALUE TODAY
$110.43
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: A is currently trading at $134.04, which is considered fair relative to its 30-day fair value range of $128.28 to $134.86. The stock's valuation (Forward PE: 20.3) is in line with its historical norms (19.6). At these levels, the market is pricing in 1.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, A is in a strong uptrend. The price is approaching resistance at $137.38. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $159.21 (+18.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, A is in a strong uptrend. The price is approaching resistance at $137.38. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $159.21 (+18.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$128.28 -
$134.86
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($159.21)
- NEUTRAL: Market pricing in 1.1% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$128.28 -
$134.86
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$127.46
Resistance Level
$137.38
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.27
Wall Street Target
$159.21
(+18.8%)
Revenue Growth (YoY)
10.0%
Earnings Growth (YoY)
60.0%
Profit Margin
19.6%
Valuation Premium vs History
+1.1% premium
PE vs Historical
20.3 vs 19.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.1%
(market-implied from PE analysis)
1-Year Target
$135.51
(+1%)
2-Year Target
$137.01
(+2%)
3-Year Target
$138.51
(+3%)
3-Yr Target (if PE normalizes)
(PE: 20→20)
PE COMPRESSION
$133.92
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 9.1%)
$187.04
(+40%)
Base:
(SPY PE: 20.3, Growth: 9.1%)
$174.09
(+30%)
Bear:
(PE: 17.2, Growth: 9.1%)
$147.97
(+10%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (26x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 25.89 | Current EPS (TTM): $5.16
Bull Case
$188.31
(+40%)
Analyst growth 28.1%, PE expands to 28.5
Base Case
$171.19
(+28%)
Market implied 28.1%, PE stable at 25.9
Bear Case
$90.84
(-32%)
Severe decline -20.0%, PE contracts to 22.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 13, 2026 5:34 PM ET
Data refreshes hourly during market hours. Next update: 6:34 PM
Data refreshes hourly during market hours. Next update: 6:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is A showing a specific setup today?
Insider Activity (6 Months)
1
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-30
Ro Khanna
SELL
2026-03-23
Ro Khanna
BUY
2026-03-10
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$591 | 64 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 67 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$157 | 60 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$271 | 54 HOLD |
Advanced A Option Strategies
Professional options setups generated by AI based on today's A price and gamma walls.
